Home/Filings/4/0001213900-24-047095
4//SEC Filing

HSU ERIC C 4

Accession 0001213900-24-047095

CIK 0001728328other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 4:26 PM ET

Size

5.5 KB

Accession

0001213900-24-047095

Insider Transaction Report

Form 4
Period: 2024-05-27
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2024-05-2754552,000 total
    Exercise: $263.18From: 2019-05-27Exp: 2024-05-27Common shares (545 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817867

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:26 PM ET
Size
5.5 KB